Company Filing History:
Years Active: 2006
Title: Innovations of Francois Germain Noel in Cardiac Treatment
Introduction
Francois Germain Noel is an accomplished inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. His work focuses on addressing critical health issues, such as congestive heart failure and muscle fatigue.
Latest Patents
Francois Germain Noel holds a patent for a compound known as Thienylhydrazon, which exhibits digitalis-like properties. This invention, characterized by its formula, includes various groups such as hydrogen, alkyl chains, and phenyl derivatives. The compound is noted for its positive inotropic effects on cardiac and skeletal muscle. Additionally, the invention outlines a novel method for synthesizing 3,4-methylenedioxybenzoyl-2-thienylhydrazone, also referred to as LASSBio-294. This compound is particularly beneficial for treating congestive heart failure and muscle fatigue, while lacking the toxic effects commonly associated with digitalis glycosides. Francois Germain Noel has 1 patent to his name.
Career Highlights
Francois Germain Noel is affiliated with the University System of Maryland, where he continues to engage in innovative research. His work has garnered attention for its potential impact on cardiac health and muscle function.
Collaborations
He has collaborated with notable colleagues, including Roberto Takashi Sudo and Edson X Albuquerque, contributing to a dynamic research environment that fosters innovation.
Conclusion
Francois Germain Noel's contributions to the field of pharmaceuticals, particularly through his patent on Thienylhydrazon, highlight his commitment to advancing medical science. His work not only addresses significant health challenges but also paves the way for future innovations in cardiac treatment.